Table 6.
Summary of potential monetary impact of INTERCEPT PLTs
| Test or procedure | Procedure mean amount $ | |
|---|---|---|
| Eliminated | ||
| Bacterial testing | 19.90 | |
| PoR | 30.32 | |
| WNV | 8.90 | |
| CMV | 5.56 | |
| T. cruzi* | 14.58 | |
| Syphilis | 7.08 | |
| Subtotal* | 71.76 | |
| Procedures eliminated | ||
| Irradiation | 8.50 | |
| Transfusion reactions work-up | 2.70 | |
| Subtotal | 11.20 | |
| Test avoided | ||
| Dengue | 20.90 | |
| Babesia | 20.90 | |
| Subtotal | 41.80 | |
| Additional from 7-day storage | 16.89 | |
| Additional savings from products not discarded due to false-positive tests | 1.27 | |
| Total* | $142.92 |
*
T. cruzi is not included in the total.